Nano Cap New Millennium Growth Fund L P Makes New Investment in Arteris, Inc. $AIP
Nano Cap New Millennium Growth Fund L P has acquired a new stake in Arteris, Inc. (NASDAQ:AIP), purchasing 123,500 shares valued at approximately $1.9 million, making it the fund's 11th largest holding. Arteris has received mixed analyst sentiment, with an average "Hold" rating and a target price of $37.75, despite recent price target increases from several firms. The company recently reported better-than-expected quarterly results, exceeding revenue and earnings per share estimates.
How Investors May Respond To Arteris (AIP) Powering Li Auto’s 5 nm AI SoCs In L9 Livis
Arteris, Inc. announced its FlexNoC 5 interconnect IP and Magillem software are powering Li Auto’s 5 nm AI SoCs in the L9 Livis smart SUV, highlighting Arteris's role in advanced automotive AI platforms. While this reinforces Arteris's position in the AI automotive market, the company continues to face challenges with profitability and rising costs, Despite analyst optimism and projected revenue growth, the stock's fair value is estimated to be significantly lower than its current price.
Arteris (AIP) CEO-managed LLC reports bona fide gift of 50,000 shares
Arteris, Inc. (AIP) CEO K. Charles Janac's managed entity, Bayview Legacy, LLC, reported a bona fide gift of 50,000 shares of common stock. This non-market, non-cash transaction at $0.00 per share is considered a personal or estate-planning move, with Bayview Legacy still beneficially owning over 8.9 million shares after the gift. Janac also holds shares directly and through a family trust, indicating no significant change in market view or company outlook.
Bayview Legacy LLC (AIP) reports bona fide gift of 50,000 Arteris shares
Bayview Legacy LLC, a 10% owner of Arteris, Inc. (AIP), reported a bona fide gift of 50,000 shares of Arteris common stock on May 18, 2026. This non-market transfer occurred at a stated price of $0.00 per share, and following the transaction, Bayview Legacy LLC indirectly holds 8,999,071 Arteris shares. K. Charles Janac, as the manager of Bayview Legacy LLC, controls these shares and also filed a separate Form 4 for the same transaction.
Arteris Technology Adopted by Li Auto for Intelligent Vehicles
Arteris, a semiconductor technology provider, announced that Li Auto Inc., a Chinese new energy vehicle (NEV) market leader, has adopted its system IP technology. This technology, including Arteris FlexNoC 5 NoC interconnect IP and Magillem software, is deployed in Li Auto's proprietary SoCs for its L9 Livis high-tech SUV to manage AI compute data movement and integration automation, ensuring high performance, energy efficiency, and functional safety for autonomous driving systems. This collaboration aims to support Li Auto's current and future intelligent vehicle innovations.
Li Auto deploys Arteris, Inc. FlexNoC IP and Magillem SoC automation for advanced vehicle integration
Li Auto has integrated Arteris, Inc.'s FlexNoC IP and Magillem SoC integration automation software into its autonomous driving system-on-chips for the L9 Livis SUV. This adoption underscores the growing importance of specialized semiconductor IP and automation tools in advancing intelligent vehicle technology. Arteris continues to strengthen its position in system connectivity, as evidenced by its previous research on NoC topology and its recognition as an innovative company.
Arteris VP and CFO Hawkins sells $7.38m in company shares
Nicholas B. Hawkins, VP and CFO of Arteris, Inc., sold 221,035 shares of company stock for approximately $7.38 million on May 15, 2026, while also acquiring 213,021 shares through stock option exercises for about $255,541. These transactions follow a 349% surge in Arteris shares over the past year and excellent Q1 2026 financial results that surpassed expectations, leading TD Cowen to raise its price target for the company. Hawkins now directly holds 110,600 shares of Arteris common stock.
Arteris VP and CFO Hawkins sells $7.38m in company shares
Nicholas B. Hawkins, VP and CFO of Arteris Inc. (NASDAQ:AIP), sold 221,035 shares of company stock for approximately $7.38 million. Concurrently, he acquired 213,021 shares by exercising stock options for about $255,541. These transactions follow a significant 349% surge in Arteris shares over the past year and recent strong financial results for Q1 2026, leading TD Cowen to raise its price target to $40.
AIP (NASDAQ) Form 144 shows proposed sales including 197,396-share exercise
Arteris, Inc. (AIP) had a Form 144 filed by Morgan Stanley Smith Barney LLC, indicating proposed dispositions of securities. This includes a restricted stock vesting of 8,014 shares on April 1, 2026, and exercise-related entries totaling 213,021 shares on May 15, 2026. The filing also reports a past sale by Nicholas Hawkins of 4,870 shares on April 2, 2026, for over $85,000.
Arteris (AIP) Revenue Growth With Persistent EPS Loss Tests Bullish Narratives In Q1 2026
Arteris (AIP) reported Q1 2026 revenue of US$22.9 million and a basic EPS loss of US$0.17, highlighting continued revenue growth alongside persistent losses. The company's valuation, at US$35.55 per share and a P/S of 21.3x, is significantly higher than its DCF fair value and industry peers, relying heavily on future revenue expectations rather than current profitability. Both bullish and bearish narratives are being tested as R&D costs remain high and margin improvements are not yet visible, despite customer traction.
Arteris director Viana sells $1.45m in company stock
Antonio J. Viana, a director at Arteris Inc. (NASDAQ:AIP), sold 40,000 shares of the company's common stock for over $1.45 million on May 13 and 14, 2026. These sales, executed under a Rule 10b5-1 trading plan, occurred while Arteris stock was trading near its 52-week high after a significant 397% surge over the past year. Despite the stock's performance, InvestingPro analysis suggests the company might be overvalued, although TD Cowen recently raised its price target for Arteris to $40 following strong Q1 2026 results.
Viana Family Trust trims Arteris (AIP) stake in planned share sales
Arteris director Antonio J. Viana, through the Viana Family Trust, sold a total of 40,000 shares of Arteris common stock (AIP) in open-market transactions on May 13th and 14th, 2026. These sales, executed under a Rule 10b5-1 trading plan established in June 2025, occurred at weighted average prices ranging from $34.0595 to $38.00 per share. Following these transactions, the Viana Family Trust holds 64,620 shares indirectly, and Antonio J. Viana holds 20,840 shares directly.
[144] Arteris, Inc. SEC Filing
This article details an SEC Form 144 filing by Arteris, Inc. (AIP) for a proposed sale of 40,839 shares of common stock. The filing, dated May 14, 2026, also lists four prior 10b5-1 transactions by the VIANA FAMILY TRUST U/A DTD 07/12/2007, each involving 20,000 shares in April and May 2026. Experts classify the filing's impact as neutral, reflecting routine disclosure obligations for an affiliate's transactional activity.
Arteris Stock Surges After Q1 Earnings Exceed Expectations
Arteris Inc. (NASDAQ: AIP) shares surged after the company reported better-than-expected Q1 earnings, with revenue of $22.94 million and an adjusted loss of three cents per share. The company also raised its full-year 2026 revenue guidance. Additionally, it was announced that CFO Nicholas Hawkins will retire on August 31, 2026.
Rule 144: AIP — Trust executed three 20,000-share 10b5-1 sales (AIP)
A Rule 144 notice filed by Morgan Stanley Smith Barney LLC on behalf of a holder discloses a planned resale of 20,000 shares of Arteris, Inc. (AIP) Common Stock, previously exercised on January 28, 2021. The filing also details three recent 10b5-1 sales by the VIANA FAMILY TRUST, each for 20,000 shares, executed on April 17, 24, and May 5, 2026, with stated gross proceeds. These transactions are procedural notifications under securities regulations concerning the resale of restricted or insider-held shares.
Arteris (AIP) Is Up 7.6% After Q1 Revenue Jump And CFO Exit News Has The Bull Case Changed?
Arteris (AIP) reported strong Q1 2026 results with a 39% year-over-year revenue increase to US$22.94 million, alongside record contract metrics, reinforcing its investment narrative for high-growth, loss-making IP. The company also announced the upcoming retirement of its CFO, Nicholas B. Hawkins, and updated its guidance. While the revenue growth and contracted backlog support the bull case driven by AI, automotive, and chiplet demand, the persistent losses and rising operating expenses, coupled with acquisition integration and CFO transition risks, remain key considerations for investors.
Arteris, Inc. (AIP) reports Q1 loss, beats revenue estimates
Arteris, Inc. (AIP) announced a Q1 loss per share of 22 cents, which was wider than the analyst estimate of a 17-cent loss. However, the company surpassed revenue expectations, reporting $13.9 million against an anticipated $13.62 million. Arteris also provided revenue guidance for Q2 and the full fiscal year 2024.
Arteris Inc stock hits all-time high at 35.43 USD
Arteris Inc. (AIP) stock reached an all-time high of $35.43, reflecting a 331.82% increase over the past year. Despite its current trading price of $32 and a $1.49 billion market cap, InvestingPro analysis suggests the stock is overvalued as the company has not been profitable in the last twelve months. The company reported strong Q1 2026 financial results, surpassing EPS and revenue expectations, demonstrating robust growth.
Arteris, Inc. (NASDAQ:AIP) Q1 2026 Earnings Call Transcript
Arteris, Inc. reported strong Q1 2026 results, exceeding revenue and ACV plus royalties guidance, driven by increased demand for advanced connectivity and security products in AI chips across various sectors. The company announced CFO Nick Hawkins' retirement but highlighted continued financial strength with no debt and positive free cash flow. Arteris also raised its full-year 2026 guidance for revenue and ACV plus royalties, anticipating continued momentum and a path to non-GAAP profitability by year-end, fueled by significant growth in royalties and licensing deals, particularly in the data center segment.
Arteris (AIP) CEO-linked Bayview Legacy LLC sells 70,000 shares under 10b5-1 plan
Arteris, Inc. (AIP) CEO K. Charles Janac, through Bayview Legacy, LLC, reported an indirect sale of 70,000 shares of common stock at a weighted average price of $31.1998 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted in March 2025. Following the sale, Bayview Legacy, LLC retains over 9 million Arteris shares, while Janac also holds direct and trust-managed shares.
Arteris, Inc. Q1 2026 Earnings Call Summary
Arteris, Inc. announced strong Q1 2026 earnings, driven by the rapid integration of AI into electronics and a significant increase in royalty revenue. The company's enterprise computing sector now leads in licensing, and its acquisition of Semifore positions it to address cybersecurity during chip development. Management raised 2026 guidance, expecting to achieve non-GAAP operating profitability by Q4 2026, despite the upcoming retirement of CFO Nick Hawkins.
[Form 4] Arteris, Inc. Insider Trading Activity
Bayview Legacy, LLC, an insider at Arteris, Inc. (AIP) and a 10% owner, reported a sale of 70,000 shares of common stock for approximately $2.18 million. This transaction occurred on May 8, 2026, at a weighted average price of $31.1998 per share, as part of a pre-arranged 10b5-1 trading plan. The sale was executed across a price range of $29.19 to $32.07, leaving Bayview Legacy, LLC with 9,049,071 shares indirectly held.
Arteris, Inc. 1Q 2026: Revenue $22.94M, EPS ($0.17) — 10-Q Summary
Arteris, Inc. (AIP) reported its first-quarter 2026 financial results, showing a significant 38.7% year-over-year revenue increase to $22.94 million. Despite the revenue growth, the company posted a net loss of ($7.96 million) and diluted loss per share of ($0.17), though this was an improvement from the prior year's loss per share. Business highlights included strong product sales, strategic pricing, and growth in direct-to-consumer channels, alongside improvements in supply chain and customer acquisition.
Arteris Announces CFO Retirement Amid Strong Growth Momentum
Arteris (AIP) reported strong first-quarter 2026 results, with revenue up 39% and record Annual Contract Value, driven by AI and space-related customer wins. Amid this growth, CFO Nick Hawkins announced his retirement effective August 31, 2026, for family reasons, but will remain as an advisor during the search for his successor. The company also updated its 2026 guidance, targeting continued growth and positive free cash flow.
Arteris president and CEO Charles Janac sells $2.18m in stock
Charles K. Janac, President and CEO of Arteris, Inc. (NASDAQ:AIP), sold 70,000 shares for over $2.18 million on May 8, 2026. The sale occurred while Arteris stock was near its 52-week high after a significant 321% surge, and an InvestingPro analysis suggested it might be overvalued. Despite this, the company recently reported strong first-quarter 2026 financial results, exceeding EPS and revenue forecasts.
Earnings Flash (AIP) Arteris, Inc. Reports Q1 Revenue $22.9M, vs. FactSet Est of $21.0M
Arteris, Inc. (AIP) reported a Q1 revenue of $22.9 million, surpassing the FactSet estimate of $21.0 million. The company's stock symbol is AIP and it is listed on Nasdaq. This financial update indicates a positive performance for Arteris relative to analyst expectations.
Net income before discontinued operations of Arteris, Inc. – LS:A3C6A9
This article provides financial context for Arteris, Inc. (LS:A3C6A9), specifically focusing on its net income before discontinued operations. It highlights company information available on TradingView, including market data from ICE Data Services and reference data from FactSet. The piece is primarily a data presentation rather than an analytical article.
EBITDA per share of Arteris, Inc. – LS:A3C6A9
The article provides a brief financial overview for Arteris, Inc. (A3C6A9) on TradingView, specifically focusing on its EBITDA per share. It indicates that the market was closed at the time of viewing. The content primarily lists navigation and platform features, with minimal actual financial data presented for the company in the provided excerpt.
Book value per share of Arteris, Inc. – LS:A3C6A9
The article focuses on the book value per share of Arteris, Inc. (A3C6A9), providing financial data accessible through the TradingView platform. It highlights various market data and reference data sources, including ICE Data Services and FactSet, and notes that SEC filings are provided by Quartr. The content serves as a financial data point for the specified company.
Tangible book value per share of Arteris, Inc. – LS:A3C6A9
This article focuses on the tangible book value per share of Arteris, Inc., identified by its stock symbol LS:A3C6A9. It appears to be a financial data point or a section from a larger financial overview of the company on a trading platform. The content is sparse, indicating a direct data display rather than an analytical piece.
Arteris, Inc. Cash Flow – LS:A3C6A9
This article provides details on Arteris, Inc.'s cash flow activities under the stock symbol A3C6A9. It reports the Free Cash Flow for Q4 2025 at 2.58 M EUR and for the full year 2025 at 4.55 M EUR, with operating cash flow at 5.73 M EUR for 2025. The data presented covers annual and quarterly cash flow from operating, investing, and financing activities from 2019 to 2025.
Net debt of Arteris, Inc. – LS:A3C6A9
The article focuses on the net debt of Arteris, Inc., identified by its Lang & Schwarz Tradecenter symbol A3C6A9. It appears to be a financial data page from TradingView, providing an overview under the "Financials" section for the company. The content primarily lists navigation and legal disclaimers associated with the data provider rather than specific financial figures.
Net current asset value per share of Arteris, Inc. – LS:A3C6A9
This article provides financial information for Arteris, Inc. (LS:A3C6A9), specifically focusing on its net current asset value per share. The content appears to be a stub or a data point from a financial platform like TradingView, indicating market closure and various data sources.
Arteris, Inc. Earnings and Revenue – LS:A3C6A9
Arteris, Inc. (A3C6A9) has reported strong financial results for the last quarter, with earnings per share of -0.04 EUR, surpassing the estimated -0.06 EUR by 24.70%. Revenue also exceeded expectations, reaching 17.15 million EUR against an estimate of 15.79 million EUR. Analysts project -0.06 EUR in earnings per share and 18.20 million EUR in revenue for the upcoming quarter.
Arteris, Inc. Financial Statements – LS:A3C6A9
This page provides financial information for Arteris, Inc. (LS:A3C6A9), a company specializing in interconnect and intellectual property technology. Key information such as market capitalization, dividend yield, and earnings are currently unavailable, and the company has no history of paying dividends. Investors can find details about the company's products and foundation on this TradingView financial page.
Arteris, Inc. Balance Sheet – LS:A3C6A9
Arteris, Inc. (A3C6A9) saw its total assets increase by 6.67% to 97.94 million EUR in Q4 2025 compared to Q3 2025. During the same period, total liabilities rose by 8.69% to 110.40 million EUR. The article provides an overview of the company's financial statements including annual and quarterly data for assets and liabilities.
Arteris, Inc. Revenue Breakdown – LS:A3C6A9
Arteris, Inc. (LS:A3C6A9) generated €60.09 million in revenue last year. The majority of this, €54.37 million, came from its top-performing "Licensing, Support and Maintenance" segment. The United States was the largest geographical contributor, accounting for €23.84 million of the revenue.
Arteris Insider Sold Shares Worth $601,464, According to a Recent SEC Filing
An insider at Arteris recently sold shares valued at $601,464, according to a new SEC filing. The document did not provide additional details beyond the transaction amount and the fact that it was an insider sale.
70,000-share 10b5-1 sale reported for AIP by Morgan Stanley Smith Barney (AIP)
Morgan Stanley Smith Barney LLC filed a Form 144 notice detailing proposed and recent sales of Common stock for accounts including BAYVIEW LEGACY, LLC and K. CHARLES JANAC. The filing highlights multiple 10b5-1 sales, such as 70,000 shares sold on April 8, 2026, for $1,332,782.00, along with other dated transactions. This disclosure is a routine compliance filing for pre-arranged sales, rather than a capital-raising action, and indicates scheduled dispositions by affiliated holders.
Arteris director Viana sells $601k of common stock
Antonio J. Viana, a director at Arteris, Inc. (NASDAQ:AIP), sold 20,000 shares of common stock for over $601,000 on May 5, 2026, executed through a 10b5-1 trading plan. This transaction occurred while the stock was near its 52-week high, having gained 311% in the past year. Following the sale, Viana maintains indirect and direct holdings in Arteris common stock.
Raman Chitkara Sells 5,000 Shares of Arteris (NASDAQ:AIP) Stock
Arteris director Raman Chitkara sold 5,000 shares of Arteris (NASDAQ:AIP) stock on May 5th for $150,250, reducing his holding by 3.38% to 142,867 shares. This sale, executed under a Rule 10b5-1 plan, follows two other sales in April, bringing his total recent insider sales to 15,000 shares. Arteris stock is currently trading around $29.75, with analysts holding an average "Hold" rating and a consensus price target of $20.17.
Arteris director Viana sells $601k of common stock
Antonio J. Viana, a director at Arteris, Inc., sold 20,000 shares of common stock for over $601,000 on May 5, 2026, via a 10b5-1 trading plan. This transaction occurred as the stock neared its 52-week high after a significant 311% gain over the past year. Viana still holds a substantial number of shares indirectly through a family trust and directly.
Arteris (AIP) director’s family trust sells 20,000 shares under 10b5-1 plan
Antonio J. Viana, a director at Arteris, Inc. (AIP), reported the Viana Family Trust's sale of 20,000 common shares. The transaction, executed under a pre-arranged Rule 10b5-1 trading plan adopted in June 2025, involved shares sold at a weighted average price of $30.0732. After the sale, the trust indirectly holds 104,620 shares, while Viana directly holds an additional 20,840 shares.
Arteris director Raman Chitkara disposes of $150,268 in stock
Arteris director Raman Chitkara sold 5,000 shares of company stock for $150,268 on May 5, 2026, pursuant to a 10b5-1 trading plan. This sale occurred after a significant 311% return over the past year, though InvestingPro data suggests the stock is currently overvalued. The transaction leaves Mr. Chitkara with 142,867 shares and follows a strong Q4 2025 earnings report where Arteris exceeded revenue and EPS expectations.
Director Raman Chitkara of Arteris (AIP) sells 5,000 shares under 10b5-1 plan
Arteris, Inc. director Raman Chitkara sold 5,000 shares of common stock at a weighted average price of $30.0536 per share on May 5, 2026. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2025. Following the sale, Chitkara directly holds 142,867 shares of Arteris common stock.
Arteris, Inc. Hits New 52-Week High at $30.75, Up 268.79%
Arteris, Inc. has reached a new 52-week high of $30.75, reflecting a significant year-over-year performance increase of 268.79%. The company has a market capitalization of $692 million and an impressive return on equity of 237.47%, despite currently being loss-making and having a high debt-to-equity ratio of 3.54. This achievement highlights Arteris's growth trajectory and dynamic market position in the Other Electrical Equipment industry.
Arteris Inc stock hits all-time high at 29.58 USD By Investing.com
Arteris Inc. (AIP) stock reached an all-time high of $29.58, currently trading at $29.51 with a market capitalization of $1.33 billion. This significant increase reflects strong investor confidence, with a 338.98% rise over the past year. Despite this, InvestingPro analysis suggests the stock might be overvalued and trading near its 52-week high with overbought technical conditions.
Viana Family Trust sells 20,000 AIP shares (NASDAQ: AIP)
The Viana Family Trust has filed a Form 144 notice indicating an intended sale of 20,000 shares of Arteris, Inc. (AIP) common stock. These shares originate from previously exercised stock options in 2021. The filing also references two recent 10b5-1 executed sales by the trust in April 2026, totaling 40,000 shares with proceeds of over $960,000.
Arteris Inc stock hits all-time high at 29.58 USD By Investing.com
Arteris Inc. (NASDAQ: AIP) stock recently reached an all-time high of $29.58, with a current trading price of $29.51 and a market capitalization of $1.33 billion. This significant increase follows a remarkable 338.98% one-year change, demonstrating strong investor confidence. The company also reported robust fourth-quarter 2025 earnings, exceeding revenue and EPS expectations, further contributing to its positive market performance despite some suggestions of overvaluation.
Insider sales reported for AIP (NASDAQ: AIP) — 5,000 RSUs disclosed
Morgan Stanley Smith Barney LLC has filed a Form 144 notice disclosing the proposed sale of 5,000 Restricted Stock Units (RSUs) granted on March 15, 2022, associated with an insider of Arteris, Inc. (AIP). The filing also details two previous 10b5-1 sales, each involving 5,000 shares, on April 14, 2026, and April 24, 2026, with reported gross proceeds of $100,254.00 and $125,289.50, respectively, executed under a 10b5-1 plan for Raman Chitkara.
